Pharmacyte BiotechPMCB
13F holders, Q2 2025 (June 30)23holders −1
2new positions
3sold out
1famous investor
$1.10avg. 13F price*
At the end of Q2 2025, 23 institutions reported holding Pharmacyte Biotech Inc. (PMCB) in their 13F filings, down 1 from Q1 2025. 2 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($214K), Geode Capital Management, LLC ($139K) and Equitec Proprietary Markets, LLC ($90K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Pharmacyte Biotech Inc.
- CUSIP
- 71715X203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $50 |
| Exits | 3 | $46 |
All 13F filers, Q1 2025 → Q2 2025: 21,685 shares bought and 13,092 shares sold, net +8,593 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Vanguard Group Inc. | 0.00% | Reduce -0.0% | 194,447 | $214K |
| Geode Capital Management, LLC | 0.00% | Reduce -8.9% | 126,603 | $139K |
| Equitec Proprietary Markets, LLC | 0.36% | No change | 82,727 | $90K |
| Renaissance Technologies | 0.00% | Add +0.6% | 49,800 | $54K |
| Susquehanna International Group, LLP | 0.00% | Add +50.0% | 27,606 | $30K |
| Schonfeld Strategic Advisors LLC | 0.00% | Add +2.8% | 26,200 | $29K |
| UBS Group AG | 0.00% | Add +89.6% | 22,592 | $25K |
| Dimensional Fund Advisors LP | 0.00% | No change | 20,299 | $22K |
| Northern Trust Corp. | 0.00% | No change | 19,208 | $21K |
| National Bank of Canada | 0.00% | No change | 3,300 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -19.0% | 2,785 | $3K |
| Bank of America Corp. | 0.00% | Add +642.5% | 542 | $591 |
| Osaic Holdings, Inc. | 0.00% | Add +2950.0% | 305 | $331 |
| Raymond James Financial Inc. | 0.00% | New | 44 | $48 |
| Park Square Financial Group, LLC | 0.00% | No change | 37 | $40 |
| Sachetta, LLC | 0.00% | No change | 14 | $16 |
| Bfsg, LLC | 0.00% | No change | 5 | $6 |
| NewEdge Advisors, LLC | 0.00% | No change | 2 | $2 |
| Koesten, Hirschmann & Crabtree, INC. | 0.00% | New | 1 | $2 |
| Morgan Stanley | 0.00% | No change | 1 | $1 |
| IFP Advisors, Inc | 0.00% | No change | 1 | $1 |
| Cwm, LLC | 0.00% | No change | 1 | $0 |
| Covestor Ltd | 0.00% | No change | 275 | $0 |
"% of holder's portfolio" is PMCB's weight in each manager's 13F, not the share of Pharmacyte Biotech Inc. the manager owns.